| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.832 | 50.382 | 75.897 | 87.383 | 97.919 | 99.155 | 106.754 | 137.072 | 134.373 |
| Total Income - EUR | - | 14.832 | 50.383 | 75.898 | 87.385 | 97.921 | 99.157 | 106.755 | 137.073 | 134.375 |
| Total Expenses - EUR | - | 7.410 | 39.626 | 37.759 | 47.784 | 53.081 | 53.028 | 42.943 | 55.994 | 66.623 |
| Gross Profit/Loss - EUR | - | 7.421 | 10.758 | 38.139 | 39.602 | 44.840 | 46.128 | 63.813 | 81.080 | 67.752 |
| Net Profit/Loss - EUR | - | 7.125 | 10.253 | 37.380 | 38.728 | 43.861 | 45.136 | 62.745 | 79.709 | 63.721 |
| Employees | - | 0 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Gabudmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 602 | 1.179 | 947 | 722 | 507 | 1.109 | 1.381 | 1.911 | 5.341 |
| Current Assets | - | 8.530 | 18.539 | 45.853 | 47.787 | 55.262 | 63.061 | 84.135 | 104.297 | 90.061 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.177 | 3.842 | 6.976 | 8.539 | 9.740 | 16.849 | 28.097 | 69.869 | 50.056 |
| Cash | - | 6.354 | 14.697 | 38.877 | 39.247 | 45.522 | 46.212 | 56.038 | 34.428 | 40.005 |
| Shareholders Funds | - | 7.169 | 17.301 | 44.298 | 45.512 | 51.298 | 60.932 | 82.296 | 103.128 | 89.358 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.963 | 2.417 | 2.502 | 2.997 | 4.470 | 3.239 | 3.219 | 3.080 | 6.045 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Gabudmed Srl